Trial Profile
Phase I trial of CPC 252 for Alzheimer's disease and Parkinsonism dementia
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 May 2014
Price :
$35
*
At a glance
- Drugs CPC 252 (Primary)
- Indications Alzheimer's disease; Dementia; Parkinsonian disorders
- Focus Adverse reactions
- 19 May 2014 New trial record